Lab to Launch: Managing the Transition From Academic Research to Commercialization

For academic researchers considering commercialization, this panel discussion will offer founders and investors sharing their journeys from early ideas to building and funding impactful companies.

Join us on Wednesday, April 22, from 5 pm to 7 pm at Princeton Innovation Center BioLabs, 303A College Road East in Princeton, NJ, for a special two-hour event hosted by Princeton Innovation Center BioLabs and Princeton University’s Office of Innovation.  

Speakers will discuss lessons learned along the way, how entrepreneurial training has shaped their thinking, and what it takes to succeed in today’s innovation.

Panelists include:

• Walida Ali (moderator), innovation development manager, Princeton University

• Demetri Maxim, founder and CEO, Nephrogen

• Alexander Pachman, venture funds manager, NJEDA

• Matthew Tamasi, founder and CEO, Plexymer

• Michael Wiley, vice president, Foundation Venture Capital Group, LLC

• Robert Wolk, chair, Catalytic Impact Foundation; founder and co-chair, Princeton Alumni Angels

Whether you are exploring entrepreneurship, building a startup, or simply curious about the path from research to real-world impact, join us for an evening of insights, practical advice, and meaningful connections within the biotech and healthcare community.

For more information and to register, click here.